This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1989 Sep 2;2(8662):569.

doi: 10.1016/s0140-6736(89)90698-3.

Recombinant human erythropoietin treatment in patients on maintenance home haemodialysis

C G Winearls, E Forman, P Wiffen, D O Oliver

PMID: 2570273
DOI: 10.1016/s0140-6736(89)90698-3

Comment

Recombinant human erythropoietin treatment in patients on maintenance home haemodialysis

C G Winearls et al. Lancet. 1989.

. 1989 Sep 2;2(8662):569.

doi: 10.1016/s0140-6736(89)90698-3.

Authors

C G Winearls, E Forman, P Wiffen, D O Oliver

PMID: 2570273
DOI: 10.1016/s0140-6736(89)90698-3

No abstract available

PubMed Disclaimer

Comment on

Recombinant human erythropoietin treatment in patients on maintenance home haemodialysis.
Pascual J, Liaño F, Matesanz R, Teruel JL, Ortuño J. Pascual J, et al. Lancet. 1989 Jul 15;2(8655):160. doi: 10.1016/s0140-6736(89)90215-8. Lancet. 1989. PMID: 2567923 No abstract available.

Similar articles

Recombinant human erythropoietin treatment in patients on maintenance home haemodialysis.
Pascual J, Liaño F, Matesanz R, Teruel JL, Ortuño J. Pascual J, et al. Lancet. 1989 Jul 15;2(8655):160. doi: 10.1016/s0140-6736(89)90215-8. Lancet. 1989. PMID: 2567923 No abstract available.
Recombinant human erythropoietin in anemic patients on maintenance hemodialysis: comparison between intravenous and subcutaneous administration.
Zehnder C, Blumberg A. Zehnder C, et al. Nephron. 1991;57(4):485-6. doi: 10.1159/000186357. Nephron. 1991. PMID: 2046836 Clinical Trial. No abstract available.
Medicare program; coverage of erythropoietin (EPO) used by competent home dialysis patients--HCFA. Interim final rule with comment period.
[No authors listed] [No authors listed] Fed Regist. 1991 Sep 4;56(171):43706-10. Fed Regist. 1991. PMID: 10113845
Recombinant human erythropoietin patient dosing algorithm.
Muirhead N. Muirhead N. Semin Nephrol. 1990 Mar;10(2 Suppl 1):59-65. Semin Nephrol. 1990. PMID: 2192418 Review. No abstract available.
Controversies in determination of epoetin (recombinant human erythropoietin) dosages.
Abraham PA, St Peter WL, Redic-Kill KA, Halstenson CE. Abraham PA, et al. Clin Pharmacokinet. 1992 Jun;22(6):409-15. doi: 10.2165/00003088-199222060-00001. Clin Pharmacokinet. 1992. PMID: 1587054 Review. No abstract available.

See all similar articles

Cited by

Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.
Faulds D, Sorkin EM. Faulds D, et al. Drugs. 1989 Dec;38(6):863-99. doi: 10.2165/00003495-198938060-00004. Drugs. 1989. PMID: 2693045 Review.
The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors.
Locatelli F, Del Vecchio L, Elliott S. Locatelli F, et al. Clin Kidney J. 2023 Aug 17;16(10):1563-1579. doi: 10.1093/ckj/sfad105. eCollection 2023 Oct. Clin Kidney J. 2023. PMID: 37779852 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science